The publication of modern slavery statements (statements) on this Register does not indicate compliance with the requirements of the Modern Slavery Act 2018 (the Act). Pursuant to section 19(2) of the Act, the Attorney-General’s Department publishes all statements properly submitted to this Register, including compliant and non-compliant statements, in order to maximise transparency and ensure entities are publicly accountable for their actions to address modern slavery risks.

Number
2022-49
Type
Single
Period
01 April 2020 to 31 March 2021
Annual revenue
150-200M
Industry sectors
Healthcare and pharmaceuticals
Countries
Japan
Key brands and business names
Takeda, Entyvio, Somac, Vyvanse, Gattex, Cuvitru
Date submitted
18/01/2022
Date published
01/02/2022